We are Entheogen Enterprises


We evaluate high-growth, high-profit potential, high-margin opportunities associated with the production, processing, beneficiation and distribution of ethnobotanic products and their derivatives as well as health & life science technologies. We participate as a responsible, active investor in mezzanine-, equity- and seed financings. With our sound corporate business development, controlling, management and engagement we accelerate the growth of these companies significantly and therefor enable them to succeed highly in their ventures. We seek opportunities to provide investors with an annualized investment return in excess of 20% with liquidity available after three years.

What we do.

We manufacture highest quality products under secure and environmental friendly conditions. Investing in growing and refining of medical cannabis has the potential to achieve significant sales and to yield extraordinary profits.

Cannabis is one of the most versatile, fast growing and resistant plants in the world and recognized for its proven pharmaceutical benefits and to treat a variety of symptoms and conditions. The market is experiencing growth due to reawakened awareness of its many medical applications. Countless studies which examined the benefits of medical cannabis have concluded that it has a highly beneficial effect on the health.

The enormous potential.

With over half a billion people and health care expenditure in the three-digit billion euros p.a. Europe is considered the potentially largest medical cannabis market in the world. Due to the increasing demand, the market is growing rapidly and exponentially. The global medical cannabis market is projected to expand by a compound annual growth rate (CAGR) of 22.4% through 2024, according to estimates from ResearchandMarkets.com. and is forecast to grow to $63.5 billion USD by 2024. Beyond the medical use companies scent a billion dollar business worldwide (i.e. cosmetic, food & beverage industry). Liberalized markets are raising hopes of establishing cannabis as a new lifestyle product.

The local benefits.

The legalization and current laws for the cultivation and processing of cannabis for medical purposes in North Macedonia grants the Entheogen Group the ability to participate in the worldwide market. North Macedonia has favorable tax policies including one of the lowest tax rates in Europe and made it into the World’s Bank Top 10 ranking of the annual flagship report “Doing Business” amongst 190 economies (higher than all but three EU member states).

In terms of operational costs, the Republic of North Macedonia is one of the most competitive locations in Europe due to low average wages, low energy costs and the availability of quality groundwater.

The Team, Network & Partners

The Entheogen Group has established an extraordinary worldwide network with strategic alliances and offers an experienced management with reputable board, supported by international advisers and experts.

Info & Contact

For detailed information on business planning, financials, management & partners as well as investment opportunities
please do inquire:
contact [at] entheogengroup.com

Back To Top